Wells Fargo analyst Larry Biegelsen lowered the firm’s price target on GE HealthCare (GEHC) to $89 from $103 and keeps an Overweight rating on the shares. The firm notes the company delivered organic growth of about 4%, while EPS beat consensus and its estimates on strong underlying trends. Given 80c incremental tariff impact, GE HealthCare cut EBIT, EPS and free cash flow guidance for 2025 but expects to mitigate in 2026, Wells adds.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- GE Healthcare Technologies Inc: Strong Growth Potential Amid Challenges with Positive Outlook
- Neutral Rating on GE Healthcare Amid Tariff Challenges and Strong Performance
- GE HealthCare Reports Strong Q1 2025 Financial Results
- GE Healthcare’s Earnings Call: Growth Amid Challenges
- GE HealthCare price target lowered to $90 from $104 at Stifel